Oncology Center of Excellence (OCE) Drug Labelling Initiative
Award Notice Posted
- Solicitation number
- 75F40120C00166
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Awarded
- to Deloitte Consulting LLP
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75F40120C00166 Federal contract award
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Place of performance
- Silver Spring MD 20993 USA
Notice details come from SAM.gov. Updated .
About this opportunity
The Award Notice announced that Deloitte was awarded a contract by the Food and Drug Administration (FDA) to support the Oncology Center of Excellence (OCE) Drug Labelling Initiative. Under contract 75F40120C00166, Deloitte will provide services to assist the FDA's OCE in developing standardized labeling for oncology drugs. The total contract value awarded to Deloitte is $8,481,821.00 over the period of performance.
Notice text
FDA Contract 75F40120C00166 has been awarded on September 16, 2020 to Deloitte [DUNS 019121586] in response to FDA solicitation FDA-RFP-1227793 in the total amount of $8,481,821.00.
Awarded contract 75F40120C00166 to DELOITTE CONSULTING LLP for 8481821.00 on 2020-09-16.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Oncology Center of Excellence (OCE) Drug Labelling Initiative | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity